VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +9.5% ·
Aktienfluss +2.3% ·
neue Nettopositionen +8.7%
· Formel
Breite Akkumulation: steigende Aktienanzahl bei mehr Inhabern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 10.99M | $194.70M | n/a | n/a |
| Q2 2026 | 150 | -1 | 757.40M | $12.03B | +6 | −6 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | n/a | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | n/a |
| Q2 2024 | 18 | n/a | 121.66M | $1.29B | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 145.12M | n/a | $1.30B | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passiv) | 82.86M | n/a | $739.95M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 3 | T. Rowe Price ✦ | 78.77M | +5.8% | $703.44M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (passiv) | 55.29M | -10.0% | $493.72M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 31.23M | +0.2% | $278.33M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Norges Bank ✦ (passiv) | 11.54M | -7.5% | $103.09M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Glenview Capital ✦ | 8.25M | -2.9% | $73.65M | 2.1% | ▼ Trim | 5 | SEC ↗ |
| 8 | Millennium Management ✦ | 7.67M | +132.9% | $68.52M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 7.53M | +1034.8% | $67.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 7.43M | +20.8% | $66.34M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Fidelity (FMR) ✦ | 6.79M | n/a | $60.67M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 12 | D. E. Shaw & Co. ✦ | 4.67M | Neu | $41.66M | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 3.21M | +47.2% | $28.69M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 14 | Gotham Asset Management ✦ | 2.71M | +232.7% | $24.20M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 948.06K | Neu | $8.47M | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 580.46K | +123.7% | $5.18M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 17 | Adage Capital Partners ✦ | 480.74K | -46.3% | $4.29M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 341.42K | -44.1% | $3.05M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 294.08K | -6.4% | $2.63M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Capital World Investors ✦ | 110.68K | 0.0% | $988,355 | 0.0% | Held | 5 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 25.78K | -98.3% | $230,251 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Soros Fund Management ✦ | 12.30K | Neu | $109,866 | 0.0% | New | 1 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 10.44K | -24.5% | $93,184 | 0.0% | ▼ Trim | 5 | SEC ↗ |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| D. E. Shaw & Co. | $41.66M | 0.0% |
| Point72 Asset Management | $8.47M | 0.0% |
| Soros Fund Management | $109,866 | 0.0% |
Ausgestiegen
| Greenlight Capital (DME… | $52.27M | war 2.6% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1,011 Inhaber, 984.50M Anteile, $12.02B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.